We are live on
!
Find out more
RCAMU
Rothschild & Co Asset Management US Portfolio holdings
AUM
$6.58B
1-Year Est. Return
4.5%
This Fund
S&P 500
This Quarter
Est. Return
+23.69%
1 Year Est. Return
-4.5%
3 Year Est. Return
+63.72%
5 Year Est. Return
+103.96%
10 Year Est. Return
–
AUM
$6.79B
AUM Growth
+$377M
(+5.9%)
Cap. Flow
-$743M
Cap. Flow
% of AUM
-10.93%
Top 10 Holdings %
Top 10 Hldgs %
13.56%
Holding
361
New
33
Increased
100
Reduced
180
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$50.8M |
| 2 |
Darden Restaurants
DRI
|
+$42M |
| 3 |
Parker-Hannifin
PH
|
+$41M |
| 4 |
Cencora
COR
|
+$26.6M |
| 5 |
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
|
+$25.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$56M |
| 2 |
AT&T
T
|
+$48.7M |
| 3 |
Gilead Sciences
GILD
|
+$48.6M |
| 4 |
QuidelOrtho
QDEL
|
+$36.3M |
| 5 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$32.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Financials | 15.82% |
| 3 | Technology | 13.99% |
| 4 | Industrials | 13.07% |
| 5 | Consumer Discretionary | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Yelp
YELP
$1.28B
| – | – |
-861,354
| Closed | -$15.5M |
|
|
PRFT
352
DELISTED
Perficient Inc
PRFT
| – | – |
-99,566
| Closed | -$2.7M |
|
|
SP
353
DELISTED
SP Plus Corporation
SP
| – | – |
-217,281
| Closed | -$4.51M |
|
|
MDRX
354
DELISTED
Veradigm Inc. Common Stock
MDRX
| – | – |
-870,037
| Closed | -$6.13M |
|
|
PACW
355
DELISTED
PacWest Bancorp
PACW
| – | – |
-577,756
| Closed | -$10.4M |
|
|
FMBI
356
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| – | – |
-86,064
| Closed | -$1.14M |
|
|
CLDR
357
DELISTED
Cloudera, Inc.
CLDR
| – | – |
-10,937
| Closed | -$86K |
|
|
PRAH
358
DELISTED
PRA Health Sciences, Inc.
PRAH
| – | – |
-200,130
| Closed | -$16.6M |
|
|
VRTU
359
DELISTED
Virtusa Corporation
VRTU
| – | – |
-90,572
| Closed | -$2.57M |
|
|
CSFL
360
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| – | – |
-226,209
| Closed | -$3.9M |
|
|
RTN
361
DELISTED
Raytheon Company
RTN
| – | – |
-79,037
| Closed | -$10.4M |
|
Similar funds
GG
AIM
AAM
PG
ZCA
GJIC
SBL
TFS
Rothschild & Co Asset Management US's Q2 2020 Portfolio in Review
As of Q2 2020, Rothschild & Co Asset Management US held 361 positions worth $6.79B, up 5.9% from $6.41B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Rothschild & Co Asset Management US withdrew a net $743M in Q2 2020, closing 46 positions and reducing 180 holdings. Its most notable exit was Gilead Sciences, an estimated $48.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Financials and Technology.
Against the trend, Rothschild & Co Asset Management US opened a new position in AbbVie worth $56.6M.
- Rothschild & Co Asset Management US's largest Q2 2020 buy was AbbVie: 576,811 shares worth $56.6M.
- Rothschild & Co Asset Management US added most to Parker-Hannifin in Q2 2020, an estimated $41M increase.
- Rothschild & Co Asset Management US's biggest Q2 2020 reduction was Procter & Gamble, cutting an estimated $56M.
- Rothschild & Co Asset Management US fully exited Gilead Sciences in Q2 2020, selling an estimated $48.6M.
- Rothschild & Co Asset Management US's ten largest holdings make up 14% of its $6.79B portfolio in Q2 2020.
- Rothschild & Co Asset Management US opened 33 new positions and closed 46 in Q2 2020.
- Rothschild & Co Asset Management US's portfolio value rose 5.9% quarter-over-quarter to $6.79B.
Based on Rothschild & Co Asset Management US's 13F filing for Q2 2020, filed 10 Aug 2020.